Nephrology clinical trials face multiple challenges, including issues with patient recruitment, a need for international sites and high costs. Due to these difficulties, only about 6 percent of current open clinical trials are for kidney disease (according to, as of October 2015).

Our experience. Your success.
At Clinipace, we have the expertise to successfully guide you through IND and CTA submissions in addition to a wide range of multi-phase global nephrology studies, including acute kidney injury, renal cell carcinoma, diabetic kidney disease, chronic kidney failure and more.

Clinipace Worldwide offers unmatched experience in renal dialysis, including:

  • Phosphate binders
  • Erythropoesis stimulating agents
  • Catheter lock solutions
  • Iron supplements
  • Calcimimetics
  • Vitamin D analogues

Our technology eliminates barriers to your success.
Low enrollment rates are a major challenge for successful nephrology trials. TEMPO™, our fully integrated, single-database technology platform, can help with patient recruitment during study management. The ability to view and monitor the number of patients enrolled at every investigator site ensures your study is on track right from the start. If enrollment is below expectations at any of your study sites, study teams can adjust strategies and quickly make decisions on how to increase enrollment.

We’ve run a wide range of multi-phase global nephrology trials, including programs for:

  • Acute kidney injury
  • Kidney transplant immuno-suppression
  • Adrenal gland neoplasms
  • Chronic kidney failure
  • Renal cell carcinoma
  • Polycystic kidney disease
  • Diabetic kidney disease
  • Renal artery obstruction

Globalize your nephrology trial and control costs.
Given the high costs typically associated with nephrology trials, a viable option is to conduct trials in developing countries with treatment-naïve patients, where costs per subject are historically lower. Clinipace has operations in countries across the globe and teams with region-specific expertise who can guide your nephrology trial to success.

Additionally, with TEMPO, you can have real-time access to global study budget data and the ability to remotely monitor patients without need for costly site visits, which ensures your study costs will be up to 30% lower than the industry average.

We’ve conducted trials across the globe in the following countries:

  • Argentina
  • Austria
  • Brazil
  • China
  • Czech Republic
  • Denmark
  • Germany
  • Hungary
  • Isreal
  • Korea
  • Latvia
  • Netherlands
  • Poland
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

Interested in Nephrology?

Let's Chat